Phase 2a data show zero cough and 60% lower treatment-related diarrhea than placebo despite higher nintedanib use in the active arm – suggesting GRI-0621 may mitigate nintedanib-related GI-toxicities when used in combination ... .
GRI) ("GRI Bio" or the "Company"), a biotechnology company advancing an innovative pipeline of NaturalKiller T (NKT) cell modulators for the treatment of inflammatory, fibrotic ...
) GLOBAL REPORTING INITIATIVE (GRI) INDEX... has reported the information cited in this GRI content index for the period January 1, 2025, to December 31, 2025, with reference to the GRI Standards.1 ... GRI 2 ... GRI 3 ... GRI 201 ... GRI 202 ... GRI 203 ... GRI 204 ... GRI 205.
) GLOBAL REPORTING INITIATIVE (GRI) INDEX... has reported the information cited in this GRI content index for the period January 1, 2025, to December 31, 2025, with reference to the GRI Standards.1 ... GRI 2 ... GRI 3 ... GRI 201 ... GRI 202 ... GRI 203 ... GRI 204 ... GRI 205.
We expect to devote substantial financial resources to our planned activities, particularly as we prepare for, initiate, and conduct our planned clinical trials of GRI-0621 and GRI-0803, advance our ...
HNI Corporation has reported the information cited in this GRI content index for the period spanning December 29, 2024, to January 3, 2026, with reference to the GRI Standards and using GRI 1 ... GRI STANDARD DISCLOSURE TITLE 2025 RESPONSE RELATED SDGS.
In previous years the Group has aligned its IntegratedAnnualReport to the GRIStandards (GRI 1 ... BP-1 Basis for preparation GRI 2-2 GRI 3-1 ... GOV-2 Oversight of sustainability IROs GRI 2-12 GRI 2-13 ... E2-3 Targets related to pollution GRI 3-3 GRI 303-2.
GRIContentIndex 2025 ... Aroundtown SA has reported the information cited in this GRI content index for the period January 1st 2025 to 31st December 2025 with reference to the GRI Standards. GRI 1 Used. GRI 1 ... GRI STANDARD DISCLOSURE LOCATION. GRI 2 ... GRI 2.